Interferon-alpha-producing cells are localized in gut-associated lymphoid tissues in transmissible gastroenteritis virus (TGEV) infected piglets

被引:2
作者
Riffault, S
Carrat, C
van Reeth, K
Pensaert, M
Charley, B [1 ]
机构
[1] INRA, Unite Virol & Immunol Mol, F-78350 Jouy En Josas, France
[2] Univ Ghent, Fac Med Vet, Virol Lab, B-9820 Merelbeke, Belgium
关键词
interferon; transmissible gastroenteritis virus (TGEV); pig; gut; lymphoid tissue;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Transmissible gastroenteritis virus (TGEV) infection of piglets results in a very rapid and massive release of IFN-alpha in serum and secretions. The objective of this work was to characterize the IFN-alpha -producing cells (IPC) in tissues of TGEV-infected piglets. Caesarean-derived colostrum-deprived piglets were infected orally with the TGEV virulent Miller strain and IPC were characterized in situ by immunohistochemistry, using a rabbit anti-pig IFN-alpha antiserum. IPC were almost exclusively detected in intestinal tissues and mesenteric lymph nodes (MLN), as early as 6 h post inoculation (p.i.), with a peak at 12-18 h. They disappeared by 24 h. IPC were localized between enterocytes in the small intestine epithelial layer, in the lamina propria, around the Peyer's patches and, at highest frequency, in MLN. Very few IPC were present in the spleen and popliteal lymph nodes of infected piglets. Double immunohistochemical staining for IFN-alpha and leukocyte markers on MLN cryosections showed that IPC were mainly Swine Leukocyte Antigen (SLA) class II positive, and were not stained by an anti-macrophage (SWC3a) MAb. In addition, double staining with anti-TGEV and anti-IFN-alpha MAbs showed that viral antigens were present in MLN, close to IPC. These results show for the first time the presence of IPC in gut mucosa and gut-associated lymphoid tissues in response to an enteropathogenic virus. Moreover, this work shows that IFN-alpha released in serum is likely to originate almost exclusively from gut IPC triggered locally by viral antigens to produce IFN-alpha, since there were very few IPC in spleen or peripheral lymph nodes. MHC class II molecule expression by gut-associated IPC suggests that these cells may be the in vivo mucosal counterparts of the dendritic cells recently shown to produce IFN-alpha after in vitro viral induction.
引用
收藏
页码:71 / 79
页数:9
相关论文
共 30 条
[1]   INTERFERON-ALPHA PRODUCTION AND TISSUE LOCALIZATION OF INTERFERON-ALPHA/BETA PRODUCING CELLS AFTER INTRADERMAL ADMINISTRATION OF AUJESZKYS-DISEASE VIRUS-INFECTED CELLS IN PIGS [J].
ARTURSSON, K ;
LINDERSSON, M ;
VARELA, N ;
SCHEYNIUS, A ;
ALM, GV .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 41 (02) :121-129
[2]   Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes [J].
Baudoux, P ;
Carrat, C ;
Besnardeau, L ;
Charley, B ;
Laude, H .
JOURNAL OF VIROLOGY, 1998, 72 (11) :8636-8643
[3]   The neglected role of type I interferon in the T-cell response: Implications for its clinical use [J].
Belardelli, F ;
Gresser, I .
IMMUNOLOGY TODAY, 1996, 17 (08) :369-372
[4]   The function of type I interferons in antimicrobial immunity [J].
Bogdan, C .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) :419-424
[5]  
CAPOBIANCHI MR, 1985, P SOC EXP BIOL MED, V178, P551
[6]   Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon [J].
Cella, M ;
Jarrossay, D ;
Facchetti, F ;
Alebardi, O ;
Nakajima, H ;
Lanzavecchia, A ;
Colonna, M .
NATURE MEDICINE, 1999, 5 (08) :919-923
[7]   INDUCTION OF ALPHA-INTERFERON BY TRANSMISSIBLE GASTROENTERITIS CORONAVIRUS - ROLE OF TRANSMEMBRANE GLYCOPROTEIN-E1 [J].
CHARLEY, B ;
LAUDE, H .
JOURNAL OF VIROLOGY, 1988, 62 (01) :8-11
[8]   A SENSITIVE IMMUNOASSAY FOR PORCINE INTERFERON-ALPHA [J].
DEARCE, HD ;
ARTURSSON, K ;
LHARIDON, R ;
PERERS, A ;
LABONNARDIERE, C ;
ALM, GV .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 30 (04) :319-327
[9]   The interferon-alpha/beta responses of mice to herpes simplex virus studied at the blood and tissue level in vitro and in vivo [J].
Eloranta, ML ;
Sandberg, K ;
Alm, GV .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 43 (04) :355-360
[10]  
Eloranta ML, 1999, SCAND J IMMUNOL, V49, P391